
1. parasitol res. 2016 sep;115(9):3669-76. doi: 10.1007/s00436-016-5172-5. epub 2016
jun 15.

recombinant methionine aminopeptidase protein babesia microti:
immunobiochemical characterization vaccine candidate human
babesiosis.

munkhjargal t(1)(2), yokoyama n(1), igarashi i(3).

author information: 
(1)national research center protozoan diseases, obihiro university of
agriculture veterinary medicine, inada-cho, obihiro, hokkaido, 080-8555,
japan.
(2)institute veterinary medicine, zaisan-17042, ulaanbaatar, mongolia.
(3)national research center protozoan diseases, obihiro university of
agriculture veterinary medicine, inada-cho, obihiro, hokkaido, 080-8555,
japan. igarcpmi@obihiro.ac.jp.

human babesiosis important zoonotic protozoan infection world.
this first report cloning, expression, purification, and
immunobiochemical characterization methionine aminopeptidase 1 (metap1)
protein babesia microti (b. microti). gene encodes metap1 protein of
b. microti (bmmetap1) approximately 66.8 kda includes glutathione
s-transferase (gst) tag shows metap activity. bmmetap1 detected a
lysate b. microti localized cytoplasm b. microti
merozoite. rbmmetap1 found immunogenic, eliciting high antibody titer
in mice. moreover, rbmmetap1 stimulated production ifn-γ il-12 not
il-4. finally, rbmmetap1 able provide considerable protection mice
against b. microti challenge infection based reduction peak parasitemia
levels earlier clearance parasite compared control mice. taken
together, results suggest rbmmetap1 confers significant protection
against experimental b. microti infection might considered potential
vaccine target human babesiosis.

doi: 10.1007/s00436-016-5172-5 
pmid: 27306898  [indexed medline]

